Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.

Tavazzi E, Bergsland N, Kuhle J, Jakimovski D, Ramanathan M, Maceski AM, Tomic D, Hagemeier J, Kropshofer H, Leppert D, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R.

J Neurol. 2020 Mar;267(3):802-811. doi: 10.1007/s00415-019-09643-z. Epub 2019 Nov 25.

PMID:
31768628
2.

Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Bergsland N, Tavazzi E, Schweser F, Jakimovski D, Hagemeier J, Dwyer MG, Zivadinov R.

CNS Drugs. 2019 Nov;33(11):1073-1086. doi: 10.1007/s40263-019-00668-6.

PMID:
31556017
3.

Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.

Bergsland N, Ramasamy D, Tavazzi E, Hojnacki D, Weinstock-Guttman B, Zivadinov R.

AJNR Am J Neuroradiol. 2019 Apr;40(4):620-625. doi: 10.3174/ajnr.A6011. Epub 2019 Mar 14.

4.

Intensive Multimodal Training to Improve Gait Resistance, Mobility, Balance and Cognitive Function in Persons With Multiple Sclerosis: A Pilot Randomized Controlled Trial.

Jonsdottir J, Gervasoni E, Bowman T, Bertoni R, Tavazzi E, Rovaris M, Cattaneo D.

Front Neurol. 2018 Sep 28;9:800. doi: 10.3389/fneur.2018.00800. eCollection 2018.

5.

Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis.

Zivadinov R, Tavazzi E, Bergsland N, Hagemeier J, Lin F, Dwyer MG, Carl E, Kolb C, Hojnacki D, Ramasamy D, Durfee J, Weinstock-Guttman B, Schweser F.

Radiology. 2018 Nov;289(2):487-496. doi: 10.1148/radiol.2018180136. Epub 2018 Jul 17.

6.

The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.

Zivadinov R, Tavazzi E, Hagemeier J, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B.

CNS Drugs. 2018 Aug;32(8):763-770. doi: 10.1007/s40263-018-0521-9.

PMID:
29767815
7.

Effects of motor rehabilitation on mobility and brain plasticity in multiple sclerosis: a structural and functional MRI study.

Tavazzi E, Bergsland N, Cattaneo D, Gervasoni E, Laganà MM, Dipasquale O, Grosso C, Saibene FL, Baglio F, Rovaris M.

J Neurol. 2018 Jun;265(6):1393-1401. doi: 10.1007/s00415-018-8859-y. Epub 2018 Apr 7.

PMID:
29627940
8.

Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.

Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D, Weinstock-Guttman B.

J Neurol Sci. 2018 Apr 15;387:152-156. doi: 10.1016/j.jns.2018.02.023. Epub 2018 Feb 10.

PMID:
29571854
9.

Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.

Zivadinov R, Hagemeier J, Bergsland N, Tavazzi E, Weinstock-Guttman B.

Eur J Neurol. 2018 Mar;25(3):584-e36. doi: 10.1111/ene.13562.

PMID:
29316038
10.

Multidisciplinary Rehabilitation is Efficacious and Induces Neural Plasticity in Multiple Sclerosis even when Complicated by Progressive Multifocal Leukoencephalopathy.

Groppo E, Baglio F, Cattaneo D, Tavazzi E, Bergsland N, Di Tella S, Parelli R, Carpinella I, Grosso C, Capra R, Rovaris M.

Front Neurol. 2017 Sep 19;8:491. doi: 10.3389/fneur.2017.00491. eCollection 2017.

11.

Serum iron concentration is associated with subcortical deep gray matter iron levels in multiple sclerosis patients.

Bergsland N, Agostini S, Laganà MM, Mancuso R, Mendozzi L, Tavazzi E, Cecconi P, Clerici M, Baglio F.

Neuroreport. 2017 Aug 2;28(11):645-648. doi: 10.1097/WNR.0000000000000804.

PMID:
28509815
12.

White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis.

Bergsland N, Tavazzi E, Laganà MM, Baglio F, Cecconi P, Viotti S, Zivadinov R, Baselli G, Rovaris M.

J Neuroimaging. 2017 Jan;27(1):107-113. doi: 10.1111/jon.12364. Epub 2016 May 30.

PMID:
27239049
13.

Corticospinal tract integrity is related to primary motor cortex thinning in relapsing-remitting multiple sclerosis.

Bergsland N, Laganà MM, Tavazzi E, Caffini M, Tortorella P, Baglio F, Baselli G, Rovaris M.

Mult Scler. 2015 Dec;21(14):1771-80. doi: 10.1177/1352458515576985. Epub 2015 Mar 19.

PMID:
25791368
14.

Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.

Tavazzi E, Laganà MM, Bergsland N, Tortorella P, Pinardi G, Lunetta C, Corbo M, Rovaris M.

Neurol Sci. 2015 Mar;36(3):371-7. doi: 10.1007/s10072-014-1954-7. Epub 2014 Sep 17.

PMID:
25228014
15.

Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection.

Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T.

Curr HIV Res. 2014;12(2):97-110.

16.

Determinants of disability in multiple sclerosis: an immunological and MRI study.

Tortorella P, Laganà MM, Saresella M, Tavazzi E, Preti MG, Ricci C, Baglio F, Marventano I, Piancone F, Baselli G, Cecconi P, Caputo D, Clerici M, Rovaris M.

Biomed Res Int. 2014;2014:875768. doi: 10.1155/2014/875768. Epub 2014 Apr 9.

17.

Drug therapy for multiple sclerosis.

Tavazzi E, Rovaris M, La Mantia L.

CMAJ. 2014 Aug 5;186(11):833-40. doi: 10.1503/cmaj.130727. Epub 2014 Apr 22. Review. No abstract available.

18.

Postinfectious neurologic syndromes: a prospective cohort study.

Marchioni E, Ravaglia S, Montomoli C, Tavazzi E, Minoli L, Baldanti F, Furione M, Alfonsi E, Bergamaschi R, Romani A, Piccolo L, Zardini E, Bastianello S, Pichiecchio A, Ferrante P, Delbue S, Franciotta D, Bono G, Ceroni M.

Neurology. 2013 Mar 5;80(10):882-9. doi: 10.1212/WNL.0b013e3182840b95. Epub 2013 Jan 16.

PMID:
23325908
19.

Immunomodulatory therapies delay disease progression in multiple sclerosis.

Bergamaschi R, Quaglini S, Tavazzi E, Amato MP, Paolicelli D, Zipoli V, Romani A, Tortorella C, Portaccio E, D'Onghia M, Garberi F, Bargiggia V, Trojano M.

Mult Scler. 2016 Nov;22(13):1732-1740. Epub 2012 May 31.

PMID:
22653657
20.

Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.

Zanin V, Delbue S, Marcuzzi A, Tavazzi E, Del Savio R, Crovella S, Marchioni E, Ferrante P, Comar M.

J Neurovirol. 2012 Oct;18(5):416-22. doi: 10.1007/s13365-012-0109-y. Epub 2012 May 12.

PMID:
22581428
21.

JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.

Delbue S, Elia F, Carloni C, Tavazzi E, Marchioni E, Carluccio S, Signorini L, Novati S, Maserati R, Ferrante P.

J Cell Physiol. 2012 Oct;227(10):3511-7. doi: 10.1002/jcp.24051.

22.

Advanced magnetic resonance imaging of neuromyelitis optica: a multiparametric approach.

Pichiecchio A, Tavazzi E, Poloni G, Ponzio M, Palesi F, Pasin M, Piccolo L, Tosello D, Romani A, Bergamaschi R, Piccolo G, Bastianello S.

Mult Scler. 2012 Jun;18(6):817-24. doi: 10.1177/1352458511431072. Epub 2011 Dec 19.

PMID:
22183930
23.

Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.

Tavazzi E, Ferrante P, Khalili K.

Clin Microbiol Infect. 2011 Dec;17(12):1776-80. doi: 10.1111/j.1469-0691.2011.03653.x. Review.

24.

Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature.

Cortese A, Baldanti F, Tavazzi E, Carnevale L, Minoli L, Lozza A, Marchioni E.

J Neurol Sci. 2012 Jan 15;312(1-2):173-6. doi: 10.1016/j.jns.2011.08.047. Epub 2011 Oct 13. Review.

PMID:
22000408
25.

Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Tavazzi E, White MK, Khalili K.

Rev Med Virol. 2012 Jan;22(1):18-32. doi: 10.1002/rmv.710. Epub 2011 Sep 21. Review.

26.

Neuropsychological evaluation and follow up in jcv- and non-jcv-related leukoencephalopathies in HIV infection.

Zucchella C, Sinforiani E, Tavazzi E, Del Bue S, Novati S, Maserati R, Ceroni M, Bastianello S, Minoli L, Ferrante P, Marchioni E.

Neurol Sci. 2011 Oct;32(5):833-9. doi: 10.1007/s10072-011-0626-0. Epub 2011 Jun 1.

PMID:
21630038
27.

ADEM as a niche variant of post infectious neurological syndromes.

Marchioni E, Tavazzi E, Franciotta D.

J Neuroimmunol. 2011 Jul;236(1-2):123. doi: 10.1016/j.jneuroim.2011.04.013. Epub 2011 May 17. No abstract available.

PMID:
21592587
28.

Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjögren syndrome.

Piccolo G, Tavazzi E, Jarius S, Alfonsi E, Cavagna L, Piccolo L, Zardini E, Voltz R, Franciotta D.

Neurol Sci. 2011 Oct;32(5):915-7. doi: 10.1007/s10072-011-0510-y. Epub 2011 Mar 3.

PMID:
21369848
29.

Acute transient inflammatory leukoencephalopathy in HIV.

Tavazzi E, Magrassi L, Maccabruni A, Bargiggia V, Pichiecchio A, Delbue S, Ferrante P, Minoli L, Marchioni E.

Neurol Sci. 2011 Oct;32(5):899-902. doi: 10.1007/s10072-010-0471-6. Epub 2011 Jan 14.

PMID:
21234774
30.

Late onset oculopharyngeal muscular dystrophy with prominent neurogenic features and short GCG trinucleotide expansion.

Piccolo G, Cortese A, Tavazzi E, Piccolo L, Sassone J, Ciammola A, Alfonsi E, Colombo I, Moggio M.

Muscle Nerve. 2011 Jan;43(1):141-2. doi: 10.1002/mus.21842. No abstract available.

PMID:
21171103
31.

Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.

Franciotta D, Di Stefano AL, Jarius S, Zardini E, Tavazzi E, Ballerini C, Marchioni E, Bergamaschi R, Ceroni M.

J Neuroimmunol. 2011 Jan;230(1-2):160-3. doi: 10.1016/j.jneuroim.2010.10.027. Epub 2010 Nov 24.

PMID:
21109310
32.

HIV-related acute inflammatory leukoencephalopathy of undetermined origin: review of the literature.

Tavazzi E, Bargiggia V, Pichiecchio A, Delbue S, Maserati R, Bastianello S, Ferrante P, Minoli L, Ricevuti G, Ceroni M, Marchioni E.

Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):693-700. Review.

PMID:
20943038
33.

Epileptic mechanisms in Charles Bonnet syndrome.

Ossola M, Romani A, Tavazzi E, Pichiecchio A, Galimberti CA.

Epilepsy Behav. 2010 May;18(1-2):119-22. doi: 10.1016/j.yebeh.2010.03.010. Epub 2010 May 14.

PMID:
20471325
34.

Non-multiple sclerosis recurrent demyelinating disorders: an ongoing debate.

Marchioni E, Tavazzi E, Bastianello S.

Brain. 2010 Aug;133(Pt 8):e150; author reply e151. doi: 10.1093/brain/awq098. Epub 2010 Apr 30. No abstract available.

PMID:
20435629
35.

Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies.

Piccolo G, Tavazzi E, Cavallaro T, Romani A, Scelsi R, Martino G.

J Neurol Sci. 2010 Mar 15;290(1-2):148-9. doi: 10.1016/j.jns.2009.12.006. Epub 2010 Jan 6.

PMID:
20056249
36.

Lymphotropic polyomavirus is detected in peripheral blood from immunocompromised and healthy subjects.

Delbue S, Tremolada S, Elia F, Carloni C, Amico S, Tavazzi E, Marchioni E, Novati S, Maserati R, Ferrante P.

J Clin Virol. 2010 Feb;47(2):156-60. doi: 10.1016/j.jcv.2009.11.029. Epub 2009 Dec 29.

37.

Varicella zoster virus-associated polyradiculoneuritis.

Cortese A, Tavazzi E, Delbue S, Alfonsi E, Pichiecchio A, Ceroni M, Ferrante P, Marchioni E.

Neurology. 2009 Oct 20;73(16):1334-5. doi: 10.1212/WNL.0b013e3181bd13b3. No abstract available.

PMID:
19841388
38.

Unusual presentation of phosphoglycerate mutase deficiency due to two different mutations in PGAM-M gene.

Tonin P, Bruno C, Cassandrini D, Savio C, Tavazzi E, Tomelleri G, Piccolo G.

Neuromuscul Disord. 2009 Nov;19(11):776-8. doi: 10.1016/j.nmd.2009.08.007. Epub 2009 Sep 23.

PMID:
19783439
39.

Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful?

Pichiecchio A, Poloni GU, Ravaglia S, Ponzio M, Germani G, Maranzana D, Costa A, Repetto A, Tavazzi E, Danesino C, Moglia A, Bastianello S.

Muscle Nerve. 2009 Jul;40(1):122-5. doi: 10.1002/mus.21304.

PMID:
19533640
40.

Combined central and peripheral demyelination: comparison of adult and pediatric series.

Ravaglia S, Tavazzi E, Moglia A, Ceroni M, Marchioni E.

Pediatr Neurol. 2009 Jul;41(1):77; author reply 77-8. doi: 10.1016/j.pediatrneurol.2009.03.001. No abstract available.

PMID:
19520285
41.

MR peri-CSF lesions and CSF oligoclonal bands in Italian multiple sclerosis patients.

Pichiecchio A, Tavazzi E, Maccabelli G, Ponzio M, Romani A, Schiappacassa R, Poloni GU, Franciotta D, Roccatagliata L, Bergamaschi R, Bastianello S.

Acta Neurol Scand. 2009 Oct;120(4):242-5. doi: 10.1111/j.1600-0404.2008.01147.x. Epub 2008 Dec 22.

PMID:
19154539
42.

NMO-IgG-negative relapsing myelitis.

Ravaglia S, Bastianello S, Franciotta D, Ceroni M, Pichiecchio A, Tavazzi E, Moglia A, Marchioni E.

Spinal Cord. 2009 Jul;47(7):531-7. doi: 10.1038/sc.2008.157. Epub 2008 Dec 23.

PMID:
19104509
43.

JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy.

Delbue S, Branchetti E, Bertolacci S, Tavazzi E, Marchioni E, Maserati R, Minnucci G, Tremolada S, Vago G, Ferrante P.

J Neurovirol. 2009 Jan;15(1):51-6. doi: 10.1080/13550280802425467. Epub 2008 Nov 27.

44.

What insights have new imaging techniques given into aggressive forms of MS--different forms of MS or different from MS?

Pichiecchio A, Tavazzi E, Maccabelli G, Precupanu CM, Romani A, Roccatagliata L, Luccichenti G, Bergamaschi R, Bastianello S.

Mult Scler. 2009 Mar;15(3):285-93. doi: 10.1177/1352458508098561. Epub 2008 Nov 27. Review.

PMID:
19039023
45.

Acute disseminated encephalomyelitis.

Marchioni E, Tavazzi E, Minoli L, Del Bue S, Ferrante P, Piccolo G, Bastianello S, Ravaglia S.

Neurol Sci. 2008 Sep;29 Suppl 2:S286-8. doi: 10.1007/s10072-008-0966-6. Review.

PMID:
18690521
46.

Varicella zoster virus meningo-encephalo-myelitis in an immunocompetent patient.

Tavazzi E, Minoli L, Ferrante P, Scagnelli P, Del Bue S, Romani A, Ravaglia S, Marchioni E.

Neurol Sci. 2008 Sep;29(4):279-83. doi: 10.1007/s10072-008-0982-6. Epub 2008 Sep 20.

47.

Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus.

Marchioni E, Bono G, Tavazzi E, Antinori A, Minoli L, Ceroni M; Italian Postinfectious Demyelinating Diseases (IPoDD) Study Group; Italian Study Group of Neuroinfectious Diseases.

Neurol Sci. 2008 Sep;29(4):203-4. doi: 10.1007/s10072-008-0968-4. No abstract available.

48.

Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases.

Franciotta D, Columba-Cabezas S, Andreoni L, Ravaglia S, Jarius S, Romagnolo S, Tavazzi E, Bergamaschi R, Zardini E, Aloisi F, Marchioni E.

J Neuroimmunol. 2008 Aug 30;200(1-2):125-8. doi: 10.1016/j.jneuroim.2008.06.004. Epub 2008 Jul 7.

PMID:
18606457
49.

Differential diagnosis between acute disseminated encephalomyelitis and multiple sclerosis during the first episode.

Tavazzi E, Ravaglia S, Franciotta D, Marchioni E.

Arch Neurol. 2008 May;65(5):676-7; author reply 677. doi: 10.1001/archneur.65.5.676-b. No abstract available.

PMID:
18474751
50.

The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.

Bergamaschi R, Crivelli P, Rezzani C, Patti F, Solaro C, Rossi P, Restivo D, Maimone D, Romani A, Bastianello S, Tavazzi E, D'Amico E, Montomoli C, Cosi V.

J Neurol Sci. 2008 Jun 15;269(1-2):49-53. doi: 10.1016/j.jns.2007.12.021. Epub 2008 Feb 15.

PMID:
18280504

Supplemental Content

Loading ...
Support Center